Hartline Investment Corp Abbott Laboratories Transaction History

Hartline Investment Corp

$795 Million
Q3 2024

A detailed history of Hartline Investment Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Hartline Investment Corp holds 8,173 shares of ABT stock, worth $937,933. This represents 0.12% of its overall portfolio holdings.

Number of Shares

8,173

Previous 8,173 -0.0%

Holding current value

$937,933

Previous $849,000 9.66%

% of portfolio

0.12%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $874,437 - $976,091	-8,681 Reduced 51.51%	8,173 $849,000
Q1 2024 Apr 30, 2024	BUY	$109.52 - $120.96 $939,791 - $1.04 Million	8,581 Added 103.72%	16,854 $1.92 Million
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $76,424 - $91,696	-800 Reduced 8.82%	8,273 $801,000
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $862,479 - $1.01 Million	9,073 New	9,073 $996,000
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $97,987 - $118,435	960 Added 9.73%	10,822 $1.18 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $73,428 - $89,541	644 Added 6.99%	9,862 $1.17 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $74,401 - $91,100	-644 Reduced 6.53%	9,218 $1.3 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $101,558 - $119,548	-960 Reduced 8.87%	9,862 $1.14 Million
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $5,250 - $5,721	50 Added 0.46%	10,822 $1.19 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $13,746 - $16,693	150 Added 1.41%	10,772 $1.17 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $11,868 - $15,190	155 Added 1.48%	10,622 $971,000
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $7,538 - $11,023	120 Added 1.16%	10,467 $826,000
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $1,727 - $1,922	-22 Reduced 0.21%	10,347 $899,000
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $7,365 - $7,986	-90 Reduced 0.86%	10,369 $868,000
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $12,754 - $14,875	-175 Reduced 1.65%	10,459 $880,000
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $2,516 - $3,042	38 Added 0.36%	10,634 $850,000
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $59,790 - $67,734	912 Added 9.42%	10,596 $766,000
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $70,965 - $85,611	-1,167 Reduced 10.75%	9,684 $710,000
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $71,847 - $79,297	1,248 Added 13.0%	10,851 $662,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $5,627 - $6,362	-100 Reduced 1.03%	9,603 $575,000
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $31,295 - $33,505	-583 Reduced 5.67%	9,703 $554,000
Q3 2017 Nov 20, 2017	BUY	$48.06 - $53.64 $494,345 - $551,741	10,286	10,286 $549,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hartline Investment Corp with notifications on news.

Account

Hartline Investment Corp Abbott Laboratories Transaction History